EMGE Emergent Health Corp (PK)

Emergent Health Corp. (Other OTC: EMGE) Emergent (the “Company”) is pleased to report approximately 90% revenue growth for the first three quarters of 2009 ($160,101.90) compared to the first three quarters of 2008 ($83,400.40). Projected earnings per share for the three quarters before income taxes are $40,108.15 (25% of revenue) or $0.002 per share. The Company believes up to 25% profitability could be ongoing with revenue growth.

The Company introduced its new improved Vita-Stim™ Stem Cell Nutrition formulation this quarter and expects product acceptance. Developmental sales of this product were made this month for export to two countries in a test market of 1048 units.

American Wellness Care, with distribution rights to Neuvitale™ Life Support to Physicians in metropolitan New York City and certain surrounding counties, has completed a reorder this month to maintain distribution rights.

The Company expects to be making some important announcements over the next 30 to 90 days relative to Board of Director and Scientific Advisory Board expansion with key people. The Company also continues to seek corporate and stock-trading transparency in positive ways.

About Emergent Health Corp.

Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. Using patented and patent pending nutritionally designed products, Emergent believes it is positioning itself as a leader in the field of Regenerative Medicine as defined by the National Institute of Health.

Sign up for Free Newsletter Updates here: http://emergenthealth.com

This press release contains certain "forward-looking" statements, defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the company.

This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.

Emergent Health (PK) (USOTC:EMGE)
Historical Stock Chart
Von Mär 2025 bis Apr 2025

Emergent Health (PK) (USOTC:EMGE)
Historical Stock Chart
Von Apr 2024 bis Apr 2025